Home6LJ0 • FRA
add
Matinas BioPharma Holdings Inc
Previous close
€2.69
Market cap
3.17M USD
P/E ratio
-
Dividend yield
-
Market news
The New York Times
21 hours ago
Stocks Extend ‘Astonishing’ Rally as Middle East Tensions Ease Further
1.20%
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.60M | -3.73% |
Net income | -1.91M | 77.33% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.60M | 59.56% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.00M | -45.10% |
Total assets | 7.21M | -42.98% |
Total liabilities | 2.38M | -52.92% |
Total equity | 4.83M | — |
Shares outstanding | 6.41M | — |
Price to book | 3.59 | — |
Return on assets | -47.33% | — |
Return on capital | -53.41% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -1.91M | 77.33% |
Cash from operations | -1.51M | 57.01% |
Cash from investing | 15.00K | -97.00% |
Cash from financing | 58.00K | 5,900.00% |
Net change in cash | -1.44M | 52.31% |
Free cash flow | -423.62K | 67.75% |
About
Founded
2013
Headquarters
Website
Employees
2
